Skip to main content
. 2022 Mar 4;2022(3):CD013739. doi: 10.1002/14651858.CD013739.pub2

ChiCTR2000030946.

Study name Effects of different VTE prevention methods on the prognosis of hospitalized patients with novel coronavirus pneumonia (COVID‐19)
Starting date 10 February 2020
Contact information Chunli Liu
The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China
+86 13560158649 | chunli@gird.cn
Methods Prospective cohort, non‐randomised, open‐label, 2 parallel and comparative arms
Participants 120 participants, 18‐80 years, female and male
Inclusion criteria
  • Patients diagnosed with new coronavirus pneumonia and in need of hospitalisation: they meet the diagnostic criteria of the diagnosis and treatment programme for new coronavirus pneumonia (trial 5th edition) issued by the National Health Commission

  • Pneumonia with novel coronavirus confirmed by aetiological nucleic acid test

  • Aged 18‐80 years

  • Signed informed consent

  • VTE score was ≥ 4, and there were no higher blood risk factors


Exclusion criteria
  • Pregnant women or lactating women

  • Severe liver function damage (Child‐Pugh grade C)

  • Severe renal impairment (CrCl ≤ 15mL/min)

  • Have any co‐existing medical conditions or diseases that the investigator determines may impair the conduct of the study

  • Social and mental disability, no legal capacity/restricted capacity

  • Refuse to sign the informed consent

  • VTE score < 4

  • Higher blood risk factors

Interventions Experimental: 7/5000 LMWH therapy
Comparison: mechanical prevention
Outcomes Primary: biochemical indicators
Secondary: not described
Notes ChiCTR2000030946 | No data provided